Estrogen-induced DNA synthesis in vascular endothelial cells is mediated by ROS signaling

BMC Cardiovascular Disorders

Volumn 6, Issue , 2006, Pages

  Felty, Quentin ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ANTIOXIDANT; APOCYNIN; BROXURIDINE; DICHLOROFLUORESCEIN; DIPHENYLIODONIUM SALT; DRUG VEHICLE; EBSELEN; ESTROGEN; ESTROGEN RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; ROTENONE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ARTICLE; ATHEROGENESIS; CARDIOVASCULAR FUNCTION; CELL GROWTH; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG DESIGN; ENDOTHELIUM CELL; EXPOSURE; GENE THERAPY; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOASSAY; MEDICAL RESEARCH; MITOCHONDRION; MONITORING; OXIDATION; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANTIOXIDANTS; CELLS, CULTURED; DNA; ENDOTHELIAL CELLS; ESTRADIOL; HUMANS; NADPH OXIDASE; NG-NITROARGININE METHYL ESTER; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 33646552677     PISSN: 14712261     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-6-16     Document Type: Article

References (40)

1. Subbiah MT: Mechanisms of cardioprotection by estrogens. Proc Soc Exp Biol Med 1998, 217:23-29.
2. Rossouw JE: Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Maturitas 2005, 51:51-63.
3. Rossouw JE: Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Maturitas 2005, 51:51-63.
4. Ramos KSCEAD Jr: Toxic Responses of the Heart and Vascular Systems. In Casarett & Doull's Toxicology: The Basic Science of Poisons 5th edition. Edited by: Klaassen CD. New York. McGraw-Hill; 1996:487-527.
5. Stier CT Jr, Chander PN, Rosenfeld L, Powers CA: Estrogen promotes microvascular pathology in female stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab 2003, 285:E232-E239.
6. Toda T, Leszczynski D, Kummerow F: Vasculotoxic effects of dietary testosterone, estradiol, and cholesterol on chick artery. J Pathol 1981, 134:219-231.
7. Villablanca A, Lubahn D, Shelby L, Lloyd K, Barthold S: Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha. Arterioscler Thromb Vasc Biol 2004, 24:1055-1061.
8. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE, Levy D: Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 2003, 290:2263-2270.
9. Lehtimaki T, Kunnas TA, Mattila KM, Perola M, Penttila A, Koivula T, Karhunen PJ: Coronary artery wall atherosclerosis in relation to the estrogen receptor I gene polymorphism: an autopsy study. J Mol Med 2002, 80:176-180.
10. Roy D, Cai Q: Estrogen, immunoactivation, gene damage, and development of breast, endometrial, ovarian, prostate, and testicular cancers. Recent Res Devel Steroid Biochem Mol Biol 2002, 3:1-32.
11. Stork S, van der Schouw YT, Grobbee DE, Bots ML: Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab 2004, 15:66-72.
12. Boehm M, Nabel EG: The cell cycle and cardiovascular diseases. Prog Cell Cycle Res 2003, 5:19-30.
13. Benditt EP, Benditt JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A 1973, 70:1753-1756.
14. Sengupta K, Banerjee S, Saxena NK, Banerjee SK: Thombospondin-I disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol. Mol Cancer Res 2004, 2:150-158.
15. Geisler J, Detre S, Berntsen H, Ottestad L, Lindtjorn B, Dowsett M, Einstein LP: Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer. Clin Cancer Res 2001, 7:1230-1236.
16. Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J, Roy D: Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 2005, 44:6900-6909.
17. Felty Q, Singh KP, Roy D: Estrogen-induced G(I)/S transition of G(0)-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 2005.
18. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F: Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997, 51:535-541.
19. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
20. DuMond JW Jr, Singh KP, Roy D: Regulation of the growth of mouse Leydig cells by the inactive stereoisomer, 17alpha-estradiol: Lack of correlation between the elevated expression of ERalpha and difference in sensitivity to estradiol isomers. Oncol Rep 2001, 8:899-902.
21. Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS: A mouse mammary tumor virus-Wnt-I transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Cancer Res 1999, 59:1869-1876.
22. Arteaga E, Villaseca P, Bianchi M, Rojas A, Marshall G: Raloxifene is a better antioxidant of low-density lipoprotein than estradiol or tamoxifen in postmenopausal women in vitro. Menopause 2003, 10:142-146.
23. Babior BM: The NADPH oxidase of endothelial cells. IUBMB Life 2000, 50:267-269.
24. Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J, Roy D: Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry 2005, 44:6900-6909.
25. Ali MH, Pearlstein DP, Mathieu CE, Schumacker PT: Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol Lung Cell Mol Physiol 2004, 287:L486-L496.
26. Souza HP, Souza LC, Anastacio VM, Pereira AC, Junqueira ML, Krieger JE, da Luz PL, Augusto O, Laurindo FR: Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radic Biol Med 2000, 28:1232-1242.
27. Wei Z, Costa K, Al-Mehdi AB, Dodia C, Muzykantov V, Fisher AB: Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ Res 1999, 85:682-689.
28. Majander A, Finel M, Wikstrom M: Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (Complex I). J Biol Chem 1994, 269:21037-21042.
29. Howard AB, Alexander RW, Nerem RM, Griendling KK, Taylor WR: Cyclic strain induces an oxidative stress in endothelial cells. Am J Physiol 1997, 272:C421-C427.
30. Ali MH, Pearlstein DP, Mathieu CE, Schumacker PT: Mitochondrial requirement for endothelial responses to cyclic strain: implications for mechanotransduction. Am J Physiol Lung Cell Mol Physiol 2004, 287:L486-L496.
31. Grimminger F, Weissmann N, Spriestersbach R, Becker E, Rosseau S, Seeger W: Effects of NADPH oxidase inhibitors on hypoxic vasoconstriction in buffer-perfused rabbit lungs. Am J Physiol 1995, 268:L747-L752.
32. Florian M, Lu Y, Angle M, Magder S: Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 2004, 69:637-645.
33. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z: Role of Racl and oxygen radicals in collagenase-I expression induced by cell shape change. Science 1998, 280:898-902.
34. Werner E, Werb Z: Integrins engage mitochondrial function for signal transduction by a mechanism dependent on Rho GTPases. J Cell Biol 2002, 158:357-368.
35. Carre M, Andre N, Carles G, Borghi H, Brichese L, Briand C, Braguer D: Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel. J Biol Chem 2002, 277:33664-33669.
36. Myhre O, Andersen JM, Aarnes H, Fonnum F: Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol 2003, 65:1575-1582.
37. Polytarchou C, Papadimitriou E: Antioxidants inhibit human endothelial cell functions through down-regulation of endothelial nitric oxide synthase activity. Eur J Pharmacol 2005, 510:31-38.
38. Cai H: Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences. Cardiovasc Res 2005.
39. Felty Q, Roy D: Potential use of J774A. I macrophage cells to biomonitor estrogenic activity in non-estrogen dependent tissue [abstract]. Vitro Cell Dev Biol 2002, 38:.
40. Benditt EP, Benditt JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A 1973, 70:1753-1756.